The FDA-approved PT-141 dose is 1.75 mg subcutaneous, taken at least 45 minutes before anticipated sexual activity. PT-141 (bremelanotide, brand name Vyleesi) is the only FDA-approved peptide for sexual dysfunction. It works through the central nervous system by activating melanocortin-4 receptors (MC4R) in the hypothalamus, not through blood flow like Viagra or Cialis.
Vyleesi was approved in June 2019 for hypoactive sexual desire disorder (HSDD) in premenopausal women, based on the RECONNECT Phase 3 trials enrolling 1,200+ women. Research protocols for males typically use the same 1.75 mg dose or slightly lower (1.0 to 1.5 mg).
| Quick Reference | Details |
|---|---|
| Drug | PT-141 / Bremelanotide (Vyleesi) |
| Mechanism | Melanocortin-4 receptor (MC4R) agonist |
| FDA-approved dose | 1.75 mg in 0.3 mL pre-filled syringe |
| Administration | Subcutaneous injection |
| Timing | At least 45 minutes before activity |
| Onset of action | 30-60 minutes |
| Duration of effect | 6-72 hours (individual variation) |
| Frequency limit | Max 1 dose per 24 hours, max 8 doses per month |
| Primary side effect | Nausea (up to 40%) |
| FDA indication | HSDD in premenopausal women |
| Derived from | Melanotan II (tanning effects removed) |
This article covers the FDA-approved protocol, research dosing for males, first-time protocols, side effect management, and frequency guidelines.
This is educational content. Consult a healthcare provider before starting any medication.
Get your custom peptide protocol:
- Tailored to your body and goals
- Precise dosing and cycle length
- Safe stacking combinations
- Backed by peer-reviewed studies
- Ready in under 2 minutes
How PT-141 Works
PT-141 activates melanocortin-4 receptors in the hypothalamus, the brain region that controls arousal, appetite, and stress response. This is a fundamentally different mechanism from PDE5 inhibitors like Viagra (sildenafil) and Cialis (tadalafil), which work by increasing blood flow to the genitals.
The distinction matters because PT-141 works for people who do not respond to Viagra or Cialis. If the issue is desire (wanting sexual activity) rather than mechanics (blood flow), PT-141 addresses the root cause. PDE5 inhibitors improve erection quality but do nothing for desire.
PT-141 was derived from Melanotan II, a peptide originally developed for sunless tanning. Researchers noticed that Melanotan II caused spontaneous arousal in clinical trial participants. PT-141 was engineered to isolate the arousal effect while removing the tanning properties.
For more on peptides that affect sexual function, see our libido and sexual health guide.
PT-141 Dosage Chart
| Population | Dose | Timing | Max Frequency |
|---|---|---|---|
| FDA-approved (women, HSDD) | 1.75 mg | 45+ min before activity | 1x/24h, 8x/month |
| Research protocol (men) | 1.0-2.0 mg | 45-60 min before activity | 2-3x/week max |
| First-time test dose | 0.5-1.0 mg | 45+ min before | Once, assess response |
| Research sweet spot (men) | 1.5-1.75 mg | 45-60 min before | 24+ hours between doses |
The 1.75 mg dose is the established standard. Going higher does not proportionally increase efficacy but does increase side effects, particularly nausea. Research consistently shows diminishing returns above 2.0 mg.
First-Time Protocol
PT-141 causes nausea in up to 40% of users, and the effect is dose-dependent. A conservative first-time approach reduces the risk of a strongly negative experience.
- 1.Start with 0.5 to 1.0 mg subcutaneous as a test dose.
- 2.Wait 30 minutes. Assess nausea and any other effects.
- 3.If tolerated, an additional 0.5 to 1.0 mg can be administered 30 minutes later.
- 4.Total first-time dose should not exceed 1.75 mg.
- 5.For subsequent uses, start directly at the tolerated dose.
Some users find that nausea diminishes with repeated use as the body adjusts. Others experience nausea consistently. Having ginger tea or an anti-nausea remedy available for the first dose is practical.
Male Dosing
PT-141 is not FDA-approved for male sexual dysfunction. However, it has been studied in males, and research protocols typically use 1.0 to 2.0 mg subcutaneous. The RECONNECT trials enrolled only women, so male dosing is extrapolated from Phase 2 data and off-label clinical practice.
Phase 2 trials in men with erectile dysfunction found that PT-141 at doses of 1.25 to 1.75 mg produced statistically significant improvement in erectile function compared to placebo. The effect was observed even in men who had not responded to sildenafil (Viagra).
The practical protocol for males: - Standard dose: 1.5 to 1.75 mg subcutaneous - Timing: 45 to 60 minutes before anticipated activity - Frequency: No more than 2 to 3 times per week - Minimum interval: 24 hours between doses
Reconstitution and Preparation
PT-141 is commonly available as a lyophilized (freeze-dried) powder in vials of 10 mg. Reconstitution requires bacteriostatic water.
| Vial Size | Bac Water | Concentration | Dose per 1.75 mg |
|---|---|---|---|
| 10 mg | 2 mL | 5 mg/mL | 0.35 mL (35 units) |
| 10 mg | 1 mL | 10 mg/mL | 0.175 mL (17.5 units) |
Using 2 mL of bacteriostatic water is recommended for easier measurement on a standard insulin syringe. At 5 mg/mL concentration, 35 units on a U-100 insulin syringe delivers exactly 1.75 mg.
For a 1.5 mg dose: 30 units (0.30 mL) at 5 mg/mL concentration. For a 1.0 mg dose: 20 units (0.20 mL) at 5 mg/mL concentration.
Reconstituted PT-141 should be refrigerated and used within 28 days. Use our reconstitution calculator for custom calculations.
Timing and Duration
PT-141 has a longer onset and much longer duration than PDE5 inhibitors.
| Parameter | PT-141 | Viagra (Sildenafil) | Cialis (Tadalafil) |
|---|---|---|---|
| Onset | 30-60 minutes | 30-60 minutes | 30-60 minutes |
| Peak effect | 1-3 hours | 1-2 hours | 2-3 hours |
| Duration | 6-72 hours | 4-6 hours | 24-36 hours |
| Mechanism | CNS (desire) | Blood flow | Blood flow |
| Works without stimulation | Yes | No | No |
The wide duration range (6 to 72 hours) reflects significant individual variation. Most users report peak effects lasting 4 to 8 hours, with residual effects (increased sensitivity, enhanced desire) persisting for 24 to 48 hours. Some individuals report effects lasting up to 72 hours after a single dose.
The practical implication: PT-141 does not produce an instant, time-limited effect like Viagra. It creates a sustained state of enhanced desire that can last well beyond a single encounter. This is both an advantage (flexibility) and a consideration (plan accordingly).
Side Effects
Nausea is the dominant side effect. It affects up to 40% of users and is the primary reason for dose limitation.
| Side Effect | Incidence | Timing | Management |
|---|---|---|---|
| Nausea | Up to 40% | 30-60 min post-injection | Light meal before dosing, ginger |
| Flushing | 15-20% | 30-60 min post-injection | Resolves spontaneously |
| Headache | 10-15% | 1-2 hours post-injection | OTC pain relief |
| Injection site reaction | 5-10% | Immediate | Rotate injection sites |
| Blood pressure increase | Temporary | During onset | Monitor if hypertensive |
| Skin darkening | Rare | Cumulative use | Melanocortin receptor effect |
Blood pressure warning: PT-141 can cause temporary blood pressure elevation. It is contraindicated in patients with uncontrolled hypertension. The RECONNECT trials excluded patients with uncontrolled high blood pressure for this reason.
Skin hyperpigmentation: Because PT-141 activates melanocortin receptors (the same family involved in tanning), rare cases of darkened skin have been reported with repeated use. This is less common than with Melanotan II because PT-141 was designed to minimize this effect, but it is not completely eliminated.
The FDA label limits PT-141 to 8 doses per month, partly because of the blood pressure concern and partly because long-term cardiovascular safety data beyond this frequency does not exist.
PT-141 vs. Viagra and Cialis
| Feature | PT-141 | Viagra | Cialis |
|---|---|---|---|
| Mechanism | Brain (MC4R agonist) | Blood flow (PDE5 inhibitor) | Blood flow (PDE5 inhibitor) |
| Affects desire | Yes | No | No |
| Affects erection | Indirectly | Directly | Directly |
| Works in both sexes | Yes | Primarily male | Primarily male |
| FDA-approved for women | Yes (HSDD) | No | No |
| Onset | 30-60 min | 30-60 min | 30-60 min |
| Duration | 6-72 hours | 4-6 hours | 24-36 hours |
| Main side effect | Nausea (40%) | Headache (25%) | Headache (15%) |
| Works if PDE5 fails | Yes | N/A | N/A |
| Administration | Injection | Oral pill | Oral pill |
PT-141 is not a replacement for Viagra or Cialis. It addresses a different problem. PDE5 inhibitors fix the mechanical aspect (blood flow). PT-141 fixes the desire aspect (wanting sexual activity). Some practitioners combine both for patients with both desire and mechanical issues.
The injection requirement is the main barrier. Most patients prefer taking a pill to administering a subcutaneous injection. This is the primary reason PT-141 has not captured a larger market share despite its unique mechanism.
Frequently Asked Questions
What is the correct PT-141 dosage?
The FDA-approved dose is 1.75 mg subcutaneous, taken at least 45 minutes before sexual activity. Research protocols for males use 1.0 to 2.0 mg, with 1.5-1.75 mg considered the sweet spot. First-time users should start with 0.5-1.0 mg as a test dose to assess nausea tolerance.
How long does PT-141 take to work?
PT-141 onset is 30 to 60 minutes after injection. Peak effects occur 1 to 3 hours post-injection. Effects can last 6 to 72 hours depending on individual response, with most users reporting peak duration of 4 to 8 hours and residual effects lasting 24 to 48 hours.
Does PT-141 work for men?
Yes. Phase 2 clinical trials showed PT-141 at 1.25-1.75 mg significantly improved erectile function in men, including those who did not respond to Viagra. However, PT-141 is only FDA-approved for women with HSDD (Vyleesi). Male use is off-label.
How often can you take PT-141?
The FDA label limits PT-141 to 1 dose per 24 hours and a maximum of 8 doses per month. Research protocols suggest no more than 2-3 times per week with at least 24 hours between doses. These limits exist due to blood pressure concerns and limited long-term safety data at higher frequencies.
Does PT-141 cause nausea?
Yes. Nausea is the most common side effect, affecting up to 40% of users. It typically appears 30-60 minutes after injection and lasts 1-2 hours. Starting with a lower test dose (0.5-1.0 mg), eating a light meal before injection, and using ginger can help mitigate nausea.
How do you reconstitute PT-141?
Add 2 mL of bacteriostatic water to a 10 mg PT-141 vial to create a 5 mg/mL concentration. For a 1.75 mg dose, draw 35 units (0.35 mL) on a U-100 insulin syringe. Refrigerate after reconstitution and use within 28 days.
Is PT-141 the same as Melanotan II?
No. PT-141 was derived from Melanotan II but engineered to remove tanning effects while preserving the arousal mechanism. Both activate melanocortin receptors, but PT-141 is more selective for MC4R (arousal) and less active at MC1R (tanning). PT-141 is FDA-approved; Melanotan II is not.
Can you use PT-141 with Viagra?
Some practitioners combine PT-141 with PDE5 inhibitors for patients with both desire and mechanical dysfunction. PT-141 addresses desire (brain), while Viagra addresses blood flow. Combination use should only be done under medical supervision due to blood pressure considerations.
The Bottom Line
PT-141 is the only FDA-approved peptide for sexual dysfunction. The standard dose is 1.75 mg subcutaneous, taken 45+ minutes before activity, with effects lasting 6 to 72 hours. It works through the brain, not blood flow, making it effective for patients who do not respond to Viagra or Cialis.
Nausea affects up to 40% of users. Start with a 0.5 to 1.0 mg test dose. Do not exceed 1 dose per 24 hours or 8 doses per month. Monitor blood pressure if hypertensive.
Use our reconstitution calculator for mixing and measurement, and see our libido peptide guide for a broader look at peptides that affect sexual function.
This is educational content. Consult a healthcare provider before starting any medication, especially if you have cardiovascular conditions.
Not Sure Which Peptide Protocol Is Right for You?
Take our 2-minute quiz for a personalized recommendation based on your goals and health profile.
Start the Quiz →